Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target

Lauren Mifflin(Harvard University), Junying Yuan(Chinese Academy of Sciences)
Nature Reviews Drug Discovery
July 15, 2020
Cited by 479


Related Papers